364
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Do patients with a single abnormal OGTT value need a globally admitted definition such as “borderline GDM”? Pregnancy outcomes of these women and the evaluation of new inflammatory markers

, &
Pages 3782-3789 | Received 17 Jun 2020, Accepted 20 Jun 2021, Published online: 05 Jul 2021

References

  • Zimmet PZ. Diabetes and its drivers: the largest epidemic in human history? Clin Diabetes Endocrinol. 2017;3(1):1.
  • Li M-F, Ma L, Yu T-P, et al. Adverse maternal and neonatal outcomes in pregnant women with abnormal glucose metabolism. Diabetes Res Clin Pract. 2020;161:108085.
  • Shaukat Sadikot NHC. International diabetes federation diabetes atlas eighth edition. In: Suvi Karuranga JRF, Yadi Huang, Belma Malanda, editor. IDF diabetes atlas. 8th ed. Brussels (Belgium): IDF; 2017.
  • ACOG. Gestational diabetes. ACOG practice bulletin 30, gestational diabetes. Washington (DC): ACOG; 2001.
  • Naylor CD, Sermer M, Chen E, et al. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? JAMA. 1996;275(15):1165–1170.
  • Berkus MD, Langer O. Glucose tolerance test: degree of glucose abnormality correlates with neonatal outcome. Obstet Gynecol. 1993;81(3):344–348.
  • Vambergue A, Nuttens M, Verier‐Mine O, et al. Is mild gestational hyperglycaemia associated with maternal and neonatal complications? Diabet Med. 2000;17(3):203–208.
  • ACOG. Gestational diabetes. ACOG practice bulletin no. 30. Obstet Gynecol. 2001;98(3):525–538.
  • Sargın MA, Yassa M, Taymur BD, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: are they useful for predicting gestational diabetes mellitus during pregnancy? Ther Clin Risk Manage. 2016;12:657.
  • Sahbaz A, Cicekler H, Aynioglu O, et al. Comparison of the predictive value of plateletcrit with various other blood parameters in gestational diabetes development. J Obstet Gynaecol. 2016;36(5):589–593.
  • Zhou Z, Chen H, Sun M, et al. Mean platelet volume and gestational diabetes mellitus: a systematic review and meta-analysis. J Diabetes Res. 2018;2018:1–10.
  • Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Supplement 1):S81–S90.
  • Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–773.
  • Bellamy L, Casas J-P, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. The Lancet. 2009;373(9677):1773–1779.
  • Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–1868.
  • Grotegut CA, Tatineni H, Dandolu V, et al. Obstetric outcomes with a false-positive one-hour glucose challenge test by the Carpenter-Coustan criteria. J Matern Fetal Neonat Med. 2008;21(5):315–320.
  • Melamed N, Hiersch L, Hod M, et al. Is abnormal 50-g glucose-challenge testing an independent predictor of adverse pregnancy outcome? J Matern Fetal Neonat Med. 2012;25(12):2583–2587.
  • Forest J, Masse J, Garrido-Russo M. Glucose tolerance test during pregnancy: the significance of one abnormal value. Clin Biochem. 1994;27(4):299–304.
  • Gruendhammer M, Brezinka C, Lechleitner M. The number of abnormal plasma glucose values in the oral glucose tolerance test and the feto-maternal outcome of pregnancy. Eur J Obst Gynecol Reprod Biol. 2003;108(2):131–136.
  • Gezer A, Esen F, Mutlu H, et al. Prognosis of patients with positive screening but negative diagnostic test for gestational diabetes. Arch Gynecol Obstet. 2002;266(4):201–204.
  • Stamilio DM, Olsen T, Ratcliffe S, et al. False-positive 1-hour glucose challenge test and adverse perinatal outcomes. Obstet Gynecol. 2004;103(1):148–156.
  • Yogev Y, Langer O, Xenakis EM, et al. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonat Med. 2005;17(1):29–34.
  • Yee LM, Cheng YW, Liddell J, et al. 50-Gram glucose challenge test: is it indicative of outcomes in women without gestational diabetes mellitus? J Matern Fetal Neonatal Med. 2011;24(9):1102–1106.
  • McLaughlin GB, Cheng YW, Caughey AB. Women with one elevated 3-hour glucose tolerance test value: are they at risk for adverse perinatal outcomes? Am J Obstet Gynecol. 2006;194(5):e16–e19.
  • Roeckner JT, Sanchez-Ramos L, Jijon-Knupp R, et al. Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;215(3):287–297.
  • Carr DB, Newton KM, Utzschneider KM, et al. Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia. Hypertens Pregnancy. 2011;30(2):153–163.
  • Pratama R, Cristobal RJ. Association of inflammatory and hemogram parameters to gestational diabetes mellitus: Predictive value for early diagnosis during pregnancy. Eur J Obst Gynecol Reprod Biol. 2019;234:e61.
  • Mertoğlu C, Murat G, Mehmet G, et al. A study of inflammatory markers in gestational diabetes mellitus. Gynecol Obstet Reprod Med. 2019;25(1):7–11.
  • Yılmaz ZV, Yılmaz E, İçer B, et al. Association of complete blood count parameters with gestational diabetes mellitus. Gynecol Obstet Reprod Med. 2017;23(2):65–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.